Charles River Laboratories International CRL
NYSE CRL
$277.86 -3.81 (-1.35%)
As of: Sep 18, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Tax Rate Growth (1y) (2010 - 2026)

Analysis

Charles River Laboratories International (CRL) Tax Rate Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 7,521.00
Mar 28, 2026 2,249.00
Dec 27, 2025 465.00
Sep 27, 2025 1,333.00
Jun 28, 2025 500.00
Mar 29, 2025 330.00
Dec 28, 2024 -806.00
Sep 28, 2024 94.00
Jun 29, 2024 -149.00
Mar 30, 2024 410.00
Dec 30, 2023 -1,332.00
Sep 30, 2023 131.00
Jul 1, 2023 -50.00
Apr 1, 2023 658.00
Dec 31, 2022 824.00
Sep 24, 2022 602.00
Jun 25, 2022 -627.00
Mar 26, 2022 1,052.00
Dec 25, 2021 -182.00
Sep 25, 2021 -945.00